(Q43923223)

28 November 2017

title

Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline (English)

1 reference

28 November 2017

Azizi M

1

1 reference

28 November 2017

Junot C

series ordinal

2

1 reference

28 November 2017

Ezan E

series ordinal

3

1 reference

28 November 2017

Ménard J

series ordinal

4

1 reference

28 November 2017

language of work or name

1 reference

1 December 2001

1 reference

Clinical and Experimental Pharmacology and Physiology

28 November 2017

published in

1 reference

28 November 2017

volume

28

1 reference

28 November 2017

issue

12

1 reference

28 November 2017

page(s)

1066-1069

1 reference

Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Involvement of thymosin beta 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Distribution of a negative regulator of haematopoietic stem cell proliferation (AcSDKP) and thymosin beta 4 in mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Acetyl-seryl-aspartyl-lysyl-proline is a novel natural cell cycle regulator of renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Calcium: its modulation in liver by cross-talk between the actions of glucagon and calcium-mobilizing agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Captopril reduces collagen and mast cell accumulation in irradiated rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03560.X

10.1046/J.1440-1681.2001.03560.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference